UroToday2h
ASCO GU 2025: Precision Diagnostics in Prostate Cancer Treatment (PREDICT): A Phase 2 Multi-arm Biomarker-Based Study (Alliance A032102)
The primary endpoint is objective response rate, with progression-free survival a key secondary endpoint. The study includes a pre-registration step for arm determination by the molecular tumor board.
UroToday3h
ASCO GU 2025: Does Treatment for Mental Health Illness Impact Prostate Cancer Treatment and Outcomes?
Annual Symposium held in San Francisco, CA between February 13–15, 2025 was host to prostate cancer poster session. Dr. Zachary Klaassen presented the results of a population-based analysis evaluating ...
UroToday5h
ASCO GU 2025: Darolutamide + ADT in Patients with mHSPC by Disease Volume: Subgroup Analysis of the Phase 3 ARANOTE Trial
GU ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Fred Saad discussing a subgroup analysis of the phase 3 ARANOTE trial assessing darolutamide + ADT in patients with ...
UroToday7d
Adjuvant Systemic Therapies for Urothelial Carcinoma: Current Evidence and Future Directions - Jean Hoffman-Censits
Adjuvant Systemic Therapies for Urothelial Carcinoma: Current Evidence and Future Directions - Jean Hoffman-Censits ...
UroToday23d
The Role of Occupational Therapy in Intermittent Self-Catheterization for Patients - Leah Holderbaum
The Role of Occupational Therapy in Intermittent Self-Catheterization for Patients - Leah Holderbaum ...
UroToday4d
Clinical forms of 5 cases of circumcised penile cancer in immunocompetent subjects in Abidjan (Ivory Coast).
Malignant tumours of the penis are rare. Their incidence varies around the world and increases with age. Treatment is essentially surgical. Surgery may be conservative or radical. We report the ...
UroToday4d
Impact of Single-Incision Sling Placement on Female Sexual Function in Women with Stress Urinary Incontinence.
Stress urinary incontinence (SUI) is a common condition among women of childbearing age, often requiring surgical intervention. The midurethral sling (MUS), including first-generation tension-free ...
UroToday4d
Neurogenic lower urinary tract dysfunction following spinal cord injury.
A spinal cord injury (SCI) leads to neurogenic lower urinary tract dysfunction (NLUTD), which, if left untreated, can result not only in urinary incontinence and an increased risk of urinary tract ...
UroToday4d
Implementing and Optimizing Universal Germline Genetic Testing for Patients with Prostate Cancer in Clinical Practice Consider.
To advocate for universal germline genetic testing (UGGT) in prostate cancer and provide practical recommendations for its implementation. Although guidelines for germline genetic testing (GGT) in ...
UroToday4d
"Δ" Delta neobladder: a novel stentless simplified totally intracorporeal robotic technique.
To report the first case series of RARC using a simplified technique for intracorporeal stentless neobladder formation. From October 2022 to February 2023, 10 patients with high-risk bladder cancer ...
UroToday4d
Molecular profiling of bladder cancer xenografts defines relevant molecular subtypes and provides a resource for biomarker discovery.
Bladder cancer (BLCA) genomic profiling has identified molecular subtypes with distinct clinical characteristics and variable sensitivities to frontline therapy. BLCAs can be categorized into luminal ...
UroToday4d
Prediction Model for Brain Metastasis in Patients With Metastatic Germ-Cell Tumors.
Brain metastasis (BM) is an independent adverse prognostic factor in metastatic germ cell tumors (mGCT). We aimed to establish an effective and practical BM prediction model. Between January 1990 and ...